1.30Open1.30Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover0.00%IV-30.05%PremiumNov 15, 2024Expiry Date5.08Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.49Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Stoke Therapeutics Stock Discussion
In the rapidly evolving world of biotechnology, companies like Stoke Therapeutics are pioneering groundbreaking treatments that could potentially change the lives of patients with severe diseases. The recent buzz surrounding Stoke Therapeutics, particularly their work on an anti-epilepsy drug, STK-001, underscores the transformative potential of RNA-based therapies in addres...
No comment yet